# Neuraworx Medical Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuraworx-medical-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Excelsior, US
- Website: www.neuraworx.com
- Latest round: Seed (Dec 18, 2025)
- Investors on record: 5

## About

Neuraworx Medical Technologies, Inc. is a US-based company specializing in innovative solutions for brain health, utilizing advanced technology to enhance cerebrovascular function and promote neurological wellness.Neuraworx Medical Technologies, Inc. was founded in 2021 in Excelsior, US, focusing on bioelectronic solutions for brain health. The company has completed 1 deal with its most recent deal occurring on December 18, 2025.Neuraworx Medical Technologies, Inc. is dedicated to advancing brain health through its core offering, Intelligent Cerebrovascular Pacing™. This innovative technology employs a multimodal approach to enhance cerebrovascular vasomotion and optimize the function of the glymphatic system, ultimately aiming to improve cerebral fluid homeostasis and facilitate the clearance of harmful biomolecules. By targeting the recently identified glymphatic and meningeal lymphatic systems, the company addresses the critical need for efficient removal of extracellular debris from the brain, particularly as these systems decline in functionality due to age and disease. Neuraworx’s solutions cater to a diverse client base, including healthcare providers and researchers in various geographical markets, with a focus on the United States and Europe, where there is a significant demand for advanced therapeutic devices that promote neurological health.Information regarding the revenue structure of Neuraworx Medical Technologies, Inc. indicates a focus on business-to-business (B2B) transactions, primarily involving partnerships with medical institutions and research organizations interested in clinical applications of their technology. Revenue generation is expected to arise from direct sales of their flagship Intelligent Cerebrovascular Pacing™ systems, as well as potential subscription models for ongoing support and updates related to their bioelectronic solutions. The company's offerings are aimed at healthcare facilities and research labs, which engage in contractual agreements for the provision of these advanced medical devices. Specific pricing plans and transaction details are structured to meet the needs of institutional buyers, emphasizing the value of their innovative technology in improving brain health outcomes.In December 2025, Neuraworx Medical Technologies, Inc. raised an undisclosed amount of venture funding led by Nexus NeuroTech Ventures, with participation from Foothill Ventures, Verge HealthTech, and Wisconsin Alumni Research Foundation. The company will use the funding to expand its team and advance preclinical testing and regulatory planning for its bioelectronic system. Future growth initiatives include the design and launch of new products aimed at enhancing their Intelligent Cerebrovascular Pacing™ technology, with plans to enter new markets in the United States and Europe by the end of 2026.

## Funding rounds

- Seed, Dec 18, 2025 — Wisconsin Alumni Research Foundation, Foothill Ventures, Verge HealthTech, Nexus NeuroTech Ventures, Corundum Neuroscience

## Investors

- Wisconsin Alumni Research Foundation — Seed
- Foothill Ventures (https://capitalatlas.ai/funds/foothill-ventures) — Seed
- Verge HealthTech (https://capitalatlas.ai/funds/verge-healthtech) — Seed
- Nexus NeuroTech Ventures (https://capitalatlas.ai/funds/nexus-neurotech-ventures) — Seed
- Corundum Neuroscience — Seed